investor.iconplc.com investor.iconplc.com

investor.iconplc.com

ICON - Investors - ICON plc - Investor Relations

Site and Patient Recruitment. Lower-cost transactional solutions with strategic resourcing and innovative technologies. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Rare and Orphan Diseases. Global experience in all Phases of oncology drug development. Offering solutions that combine in-house expertise and proprietary innovative technology. Cardiovascular and Metabolic Disorders. 2 - 5 April, 2018.

http://investor.iconplc.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTOR.ICONPLC.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

August

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.6 out of 5 with 7 reviews
5 star
0
4 star
6
3 star
0
2 star
0
1 star
1

Hey there! Start your review of investor.iconplc.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.4 seconds

FAVICON PREVIEW

  • investor.iconplc.com

    16x16

  • investor.iconplc.com

    32x32

CONTACTS AT INVESTOR.ICONPLC.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
ICON - Investors - ICON plc - Investor Relations | investor.iconplc.com Reviews
<META>
DESCRIPTION
Site and Patient Recruitment. Lower-cost transactional solutions with strategic resourcing and innovative technologies. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Rare and Orphan Diseases. Global experience in all Phases of oncology drug development. Offering solutions that combine in-house expertise and proprietary innovative technology. Cardiovascular and Metabolic Disorders. 2 - 5 April, 2018.
<META>
KEYWORDS
1 ICON
2
3 coupons
4 reviews
5 scam
6 fraud
7 hoax
8 genuine
9 deals
10 traffic
CONTENT
Page content here
KEYWORDS ON
PAGE
investors,investigators,services,adaptive trials,biosimilars,consulting,medical imaging,laboratories,medical devices,preclinical/phase l,functional services provision,clinical research services,commercialisation and outcomes,therapeutics,internal medicine
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

ICON - Investors - ICON plc - Investor Relations | investor.iconplc.com Reviews

https://investor.iconplc.com

Site and Patient Recruitment. Lower-cost transactional solutions with strategic resourcing and innovative technologies. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Rare and Orphan Diseases. Global experience in all Phases of oncology drug development. Offering solutions that combine in-house expertise and proprietary innovative technology. Cardiovascular and Metabolic Disorders. 2 - 5 April, 2018.

INTERNAL PAGES

investor.iconplc.com investor.iconplc.com
1

ICON - Investors - ICON plc - Events & Presentations

http://investor.iconplc.com/events.cfm

Investor News ». Corporate Governance ». Articles and Committee Charters. Calendar of Events and Presentations ». Investing in ICON ». ICON Figures and Stock Information ». Reports and Documentation ». Investor Contact ». Shareholder Briefcase ». Email Alerts ». Download Library ». RSS Feeds ». Stock Price: ICLR (NASDAQ). As of 4:00 PM ET on 26 Aug 2016. ICON Figures and Stock information ». Jul 26, 2016. At 2:00 PM UK. Q2 2016 Conference Call and Webcast. Speaker: Ciaran Murray, CEO. Jul 22, 2016. 34th ...

2

ICON - Investors - ICON plc - Investor News

http://investor.iconplc.com/releases.cfm

Investor News ». Corporate Governance ». Articles and Committee Charters. Calendar of Events and Presentations ». Investing in ICON ». ICON Figures and Stock Information ». Reports and Documentation ». Investor Contact ». Shareholder Briefcase ». Email Alerts ». Download Library ». RSS Feeds ». Stock Price: ICLR (NASDAQ). As of 4:00 PM ET on 26 Aug 2016. ICON Figures and Stock information ». 26 July, 2016. ICON Reports Second Quarter 2016 Results. 25 July, 2016. 30 June, 2016. 23 June, 2016. 15 June, 2016.

3

ICON - Investors - ICON plc - FAQ

http://investor.iconplc.com/faq.cfm

Investor News ». Corporate Governance ». Articles and Committee Charters. Calendar of Events and Presentations ». Investing in ICON ». ICON Figures and Stock Information ». Reports and Documentation ». Investor Contact ». Investing in ICON ». Shareholder Briefcase ». Email Alerts ». Download Library ». RSS Feeds ». Stock Price: ICLR (NASDAQ). As of 4:00 PM ET on 26 Aug 2016. ICON Figures and Stock information ». What stock exchange is ICON listed on? To see the list of analysts. Providence, RI 02940-3001.

4

ICON - Investors - ICON plc - Board of Directors

http://investor.iconplc.com/directors.cfm

Investor News ». Corporate Governance ». Articles and Committee Charters. Calendar of Events and Presentations ». Investing in ICON ». ICON Figures and Stock Information ». Reports and Documentation ». Investor Contact ». Mr Declan McKeon - Acting Chairman. Mr Declan McKeon has served as a non- executive director of the Company since April 2010 ad has been Acting Chairman since April 2016. Chair of the Audit Committee. Member of the Nominating and Governance Committee. Mr Murray graduated with a Bachelor...

5

ICON - Investors - ICON plc - Investor Relations

http://investor.iconplc.com/index.cfm

ICON is a Global Contract Research Organisation (CRO). We specialise in the strategic development, management and analysis of programs that support Clinical Development; from compound selection to Phase I-IV clinical studies. Stock Price: ICLR (NASDAQ). As of 4:00 PM ET on 26 Aug 2016. ICON Figures and Stock information ». Corporate Governance ». Calendar of Events ». ICON Reports Second Quarter 2016 Results ». ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting ».

UPGRADE TO PREMIUM TO VIEW 4 MORE

TOTAL PAGES IN THIS WEBSITE

9

LINKS TO THIS WEBSITE

video.iconplc.com video.iconplc.com

Therapeutics - Video - ICON plc

http://video.iconplc.com/category/videos/therapeutics

Site and Patient Recruitment. Global network of CAP accredited laboratories. Extensive test menu. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Rare and Orphan Diseases. Global experience in all Phases of oncology drug development. Experience in cardiovascular trials supported by a global team of experts. Endocrine and Metabolic disorders. ICON has conducted diabetes trials in all global regions.

iconplc.com iconplc.com

Firecrest

http://www.iconplc.com/technology/firecrest

Global network of CAP accredited laboratories. Extensive test menu. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Rare and Orphan Diseases. Global experience in all Phases of oncology drug development. Experience in cardiovascular trials supported by a global team of experts. Endocrine and Metabolic disorders. ICON has conducted diabetes trials in all global regions. EU Medical Devices Regulations.

akosltd.net akosltd.net

ICON Excellence - ICON plc

http://www.akosltd.net/excellence

Global network of CAP accredited laboratories. Extensive test menu. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Rare and Orphan Diseases. Global experience in all Phases of oncology drug development. Experience in cardiovascular trials supported by a global team of experts. Endocrine and Metabolic disorders. ICON has conducted diabetes trials in all global regions. EU Medical Devices Regulations.

akosltd.com akosltd.com

Global Central Laboratories - ICON plc

http://www.akosltd.com/services/laboratories/global-central-laboratories

Global network of CAP accredited laboratories. Extensive test menu. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Rare and Orphan Diseases. Global experience in all Phases of oncology drug development. Experience in cardiovascular trials supported by a global team of experts. Endocrine and Metabolic disorders. ICON has conducted diabetes trials in all global regions. EU Medical Devices Regulations.

akosltd.com akosltd.com

Services - ICON plc

http://www.akosltd.com/services

Global network of CAP accredited laboratories. Extensive test menu. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Rare and Orphan Diseases. Global experience in all Phases of oncology drug development. Experience in cardiovascular trials supported by a global team of experts. Endocrine and Metabolic disorders. ICON has conducted diabetes trials in all global regions. EU Medical Devices Regulations.

akosltd.com akosltd.com

ICON Views

http://www.akosltd.com/icon-views

Global network of CAP accredited laboratories. Extensive test menu. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Rare and Orphan Diseases. Global experience in all Phases of oncology drug development. Experience in cardiovascular trials supported by a global team of experts. Endocrine and Metabolic disorders. ICON has conducted diabetes trials in all global regions. EU Medical Devices Regulations.

akosltd.net akosltd.net

Preclinical & Phase I Clinical Trials - ICON

http://www.akosltd.net/services/preclinical-phase-i

Global network of CAP accredited laboratories. Extensive test menu. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Rare and Orphan Diseases. Global experience in all Phases of oncology drug development. Experience in cardiovascular trials supported by a global team of experts. Endocrine and Metabolic disorders. ICON has conducted diabetes trials in all global regions. EU Medical Devices Regulations.

UPGRADE TO PREMIUM TO VIEW 103 MORE

TOTAL LINKS TO THIS WEBSITE

110

SOCIAL ENGAGEMENT



OTHER SITES

investor.hunterdouglasgroup.com investor.hunterdouglasgroup.com

Investor Relations | Hunter Douglas N.V. – IR Site

Skip to main navigation. Price (EUR or ):. Change (EUR or ):. Price (EUR or ):. Change (EUR or ):. March 7, 2018. HUNTER DOUGLAS - ANNUAL GENERAL MEETING 2018 / DIVIDEND 2017. March 7, 2018. HUNTER DOUGLAS RESULTS 2017. January 24, 2018. HUNTER DOUGLAS HAS AGREED TO ACQUIRE 80% OF DEBEL. Leen Reijtenbagh, CFO. There are currently no events to display.

investor.i58.ru investor.i58.ru

Займы под залог недвижимости «Инвестиционная компания». Пенза

Займы под залог недвижимости. ИП Стрельцов Алексей Анатольевич. Опыт работы на рынке недвижимости более 15 лет. Г Пенза, ул. Бакунина, 50Б офис 6. Режим работы: с 10:00 до 17:00. Суббота: с 10:00 до 15:00 по тел 25-75-44. Воскресенье - выходной. Телефон: 25-75-44, 39-61-16. факс: 56-45-69. Почта: kredit.penza@mail.ru. Займы под залог недвижимости Инвестиционная компания. Сейчас на сайте 1 объявление. 2 000 000 руб. Деньги наличными под 3 % в месяц под залог недвижимости в Пензе. USD 64.94 руб.

investor.ibpap.org investor.ibpap.org

IT and Business Process Association of the Philippines | Investor Portal

What BPAP can do for the Investors. About the IT-BPO and GIC in the Philippines. Where To Invest In The Philippines. Benefits of Doing Business in the Philippines. Educational Infrastructure and Talent Pool. Alignment with Western Standards. Growth in the IT-BPO and GIC industry. Philippine Labor Laws and Policies. Cost of Living in the Philippines. Number 1 in voice. Number 2 in non-voice, complex services. Why Do Business in The Philippines. This high rate of growth has persisted even as the industry h...

investor.icfi.com investor.icfi.com

Investor Overview » ICFi Investor Relations

Business Process Operations Optimization. Program Management IT Management. Strategy, Policy Analysis, Regulatory Development. ICF in the Americas. ICF in Africa the Middle East. ICF in Asia the Pacific. ICF International (NASDAQ:ICFI) provides professional services and technology solutions that deliver beneficial impact in areas critical to the world's future. ICF is fluent in the language of change, whether driven by markets, technology, or policy. 160; 0.04. Data as of 08/07/15 4:00 pm ET. Appointment...

investor.ico.com investor.ico.com

Investor Relations - Pendrell Corporation

ContentGuard mobile email app. Memory and Storage solutions. Digital Rights Management technologies. Global IP Advisory Services. Tax Benefits Preservation Plan - 2010. The investor pages that follow are provided as a resource for financial information about Pendrell Corporation (NASDAQ: PCO). Court Rejects Attempts to Limit Scope of Contentguard's Pioneering DRM Patents Through Claim Construction. Pendrell Enters into Memory Technologies Agreement with SK hynix. Pendrell Announces Leadership Changes.

investor.iconplc.com investor.iconplc.com

ICON - Investors - ICON plc - Investor Relations

Site and Patient Recruitment. Lower-cost transactional solutions with strategic resourcing and innovative technologies. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Rare and Orphan Diseases. Global experience in all Phases of oncology drug development. Offering solutions that combine in-house expertise and proprietary innovative technology. Cardiovascular and Metabolic Disorders. 2 - 5 April, 2018.

investor.id investor.id

Home | Investor Daily

Selasa, 18 April 2017. MARKET and CORPORATE NEWS. Ciputra Development Diuntungkan Penyebaran Proyek. Tren penguatan harga komoditas pertambangan dan minyak sawit mentah (crude palm oil/CPO) ditambah pengembangan infrastruktur tol Trans Jawa dan Trans Sumatera akan menjadi pendongkrak kinerja keuangan PT Ciputra Development Tbk (CTRA) ke depan. Dana Repatriasi Masuk Properti. Pertumbuhan di Atas 6%. Indonesia Perlu Belajar dari Tiongkok. Mendobrak Pamor Bandara Soekarno-Hatta. Saat traveling, dia banyak m...

investor.ifec.co.th investor.ifec.co.th

Inter Far East Energy Corporation Public Company Limited

Inter Far East Energy Corporation Public Company Limited. Extraordinary General Meeting of Shareholders No.1/2017 at 10.00 am. At Thai Army Club Viphavadi. Updated: 12 January 2017 16:37. SP sign posted against IFEC. Clarification of payment on bill of exchange (Edit the News to SET). Inter Far East Energy Corporation Public Company Limited. No 33/4, The Nine Tower, 29 th Floor, Tower B Rama IX Road., Huai Khwang Sub-district, Huai Khwang District Bangkok 10310.

investor.ifscapthai.com investor.ifscapthai.com

IFS Capital (Thailand) Public Company Limited

Hotline : (66)2 285 6326 - 32. Compensation and Normination Committee. Leasing / Hire Purchase. IFS Capital (Thailand) Public Company Limited (IFS) is an established financial institution and the leader in providing factoring services in Thailand. It is well-known and widely accepted in Thailand. With over 23 years of establishment, you can trust our excellent service and stability. Financial Statement Quarter 3/2016. Reviewed Quarter 3 F/S (F45-1). Updated: 12 January 2017 16:37. Go to Stock Chart.

investor.ifunding.com investor.ifunding.com

iFunding Investor Portal

investor.igg.com investor.igg.com

Company Profile - About IGG – Investor

The Group is a rapidly growing developer and publisher of mobile online games with a global presence and international customer base. The Group has its headquarter in Singapore with regional offices in the United States, China, Canada, Japan, Korea, Thailand and the Philippines, with customers from over 200 countries and regions around the world. Please choose your server.